{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T12:16:38Z","timestamp":1788956198645,"version":"build-2803163510"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,7,9]],"date-time":"2025-07-09T00:00:00Z","timestamp":1752019200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J011015"],"award-info":[{"award-number":["2022J011015"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2022J011015"],"award-info":[{"award-number":["2022J011015"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003392","name":"Natural Science Foundation of Fujian Province","doi-asserted-by":"crossref","award":["2023J011166"],"award-info":[{"award-number":["2023J011166"]}],"id":[{"id":"10.13039\/501100003392","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100008021","name":"Fujian University of Traditional Chinese Medicine","doi-asserted-by":"publisher","award":["X2024037"],"award-info":[{"award-number":["X2024037"]}],"id":[{"id":"10.13039\/501100008021","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Joint Funds for the innovation of science and Technology,Fujian province","award":["2024Y9486"],"award-info":[{"award-number":["2024Y9486"]}]},{"name":"Joint Funds for the innovation of science and Technology,Fujian province","award":["2023Y9292"],"award-info":[{"award-number":["2023Y9292"]}]},{"DOI":"10.13039\/501100001809","name":"National Science Foundation of China","doi-asserted-by":"crossref","award":["82174365"],"award-info":[{"award-number":["82174365"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Rehabilitation technology innovation center by joint collaboration of ministry of education and Fujian province, Fujian University of Traditional Chinese Medicine","award":["X2022009-Collaboration"],"award-info":[{"award-number":["X2022009-Collaboration"]}]},{"DOI":"10.13039\/501100017686","name":"Fujian provincial health technology project","doi-asserted-by":"crossref","award":["2021QNA001"],"award-info":[{"award-number":["2021QNA001"]}],"id":[{"id":"10.13039\/501100017686","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Major Science and Technology Project of Fujian Province","award":["2024YZ034026"],"award-info":[{"award-number":["2024YZ034026"]}]},{"name":"Youth Research and Innovation Cultivation Program of Fujian Unveristy of Tradtional Chinese Medicine","award":["XQC2023007"],"award-info":[{"award-number":["XQC2023007"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-025-03922-y","type":"journal-article","created":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:45:40Z","timestamp":1752137140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["UBC9 overexpression promotes proliferation and metastasis in gastric cancer via ATF2"],"prefix":"10.1186","volume":"23","author":[{"given":"QingShui","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ShengZhao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiNing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuluo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"QiuYan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YiMin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KeJia","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YaJuan","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yide","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minghan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FangQin","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,9]]},"reference":[{"key":"3922_CR1","doi-asserted-by":"publisher","first-page":"10","DOI":"10.3322\/caac.21871","volume":"75","author":"RL Siegel","year":"2025","unstructured":"Siegel RL, Kratzer TB, Giaquinto AN, Sung H, Jemal A. Cancer statistics, 2025. Cancer J Clin. 2025;75:10\u201345.","journal-title":"Cancer J Clin"},{"key":"3922_CR2","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1016\/S1470-2045(10)70070-X","volume":"11","author":"I Songun","year":"2010","unstructured":"Songun I, Putter H, Kranenbarg EM, Sasako M, van de Velde CJ. Surgical treatment of gastric cancer: 15-year follow-up results of the randomised nationwide Dutch D1D2 trial. Lancet Oncol. 2010;11:439\u201349.","journal-title":"Lancet Oncol"},{"key":"3922_CR3","doi-asserted-by":"publisher","first-page":"219","DOI":"10.4143\/crt.2023.340","volume":"56","author":"S Oh","year":"2024","unstructured":"Oh S, Nam SK, Lee KW, Lee HS, Park Y, Kwak Y, Lee KS, Kim JW, Kim JW, Kang M, Park YS, Ahn SH, Suh YS, Park DJ, Kim HH. Genomic and transcriptomic characterization of gastric Cancer with bone metastasis. Cancer Res Treat. 2024;56:219\u201337.","journal-title":"Cancer Res Treat"},{"key":"3922_CR4","doi-asserted-by":"publisher","first-page":"8611","DOI":"10.3748\/wjg.v19.i46.8611","volume":"19","author":"CQ Chen","year":"2013","unstructured":"Chen CQ, Wu XJ, Yu Z, Bu ZD, Zuo KQ, Li ZY, Ji JF. Prognosis of patients with gastric cancer and solitary lymph node metastasis. World J Gastroenterol. 2013;19:8611\u20138.","journal-title":"World J Gastroenterol"},{"key":"3922_CR5","doi-asserted-by":"publisher","first-page":"1229397","DOI":"10.3389\/fimmu.2023.1229397","volume":"14","author":"Y Li","year":"2023","unstructured":"Li Y, Zhang R, Hei H. Advances in post-translational modifications of proteins and cancer immunotherapy. Front Immunol. 2023;14:1229397.","journal-title":"Front Immunol"},{"key":"3922_CR6","doi-asserted-by":"publisher","first-page":"210050","DOI":"10.1098\/rsob.210050","volume":"11","author":"Z Sheng","year":"2021","unstructured":"Sheng Z, Zhu J, Deng YN, Gao S, Liang S. SUMOylation modification-mediated cell death. Open Biology. 2021;11:210050.","journal-title":"Open Biology"},{"key":"3922_CR7","first-page":"1081","volume":"52","author":"ZJ Han","year":"2018","unstructured":"Han ZJ, Feng YH, Gu BH, Li YM, Chen H. The post-translational modification, sumoylation, and cancer (Review). Int J Oncol. 2018;52:1081\u201394.","journal-title":"Int J Oncol"},{"key":"3922_CR8","doi-asserted-by":"publisher","first-page":"520","DOI":"10.1097\/CCO.0000000000000765","volume":"33","author":"L Du","year":"2021","unstructured":"Du L, Liu W, Rosen ST. Targeting sumoylation in cancer. Curr Opin Oncol. 2021;33:520\u20135.","journal-title":"Curr Opin Oncol"},{"key":"3922_CR9","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1517\/14728222.9.6.1203","volume":"9","author":"YY Mo","year":"2005","unstructured":"Mo YY, Moschos SJ. Targeting Ubc9 for cancer therapy. Expert Opin Ther Targets. 2005;9:1203\u201316.","journal-title":"Expert Opin Ther Targets"},{"key":"3922_CR10","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/187152009787047716","volume":"9","author":"X Duan","year":"2009","unstructured":"Duan X, Trent JO, Ye H. Targeting the SUMO E2 conjugating enzyme Ubc9 interaction for anti-cancer drug design. Anti-cancer Agents Med Chem. 2009;9:51\u20134.","journal-title":"Anti-cancer Agents Med Chem"},{"key":"3922_CR11","doi-asserted-by":"publisher","first-page":"4764","DOI":"10.2174\/1381612826666200622124134","volume":"26","author":"S Liu","year":"2020","unstructured":"Liu S, Wang L, Jiang D, Wei W, Nasir MF, Khan MS, Yousafi Q, Liu X, Fu X, Li X, Li J. Sumoylation as an emerging target in therapeutics against Cancer. Curr Pharm Design. 2020;26:4764\u201376.","journal-title":"Curr Pharm Design"},{"key":"3922_CR12","doi-asserted-by":"crossref","unstructured":"Mattoscio D, Chiocca S. SUMO pathway components as possible cancer biomarkers, Future oncology (London, England). 2015;11:1599\u2013\u2009610.","DOI":"10.2217\/fon.15.41"},{"key":"3922_CR13","doi-asserted-by":"publisher","first-page":"49783","DOI":"10.18632\/oncotarget.17939","volume":"8","author":"S Fang","year":"2017","unstructured":"Fang S, Qiu J, Wu Z, Bai T, Guo W. Down-regulation of UBC9 increases the sensitivity of hepatocellular carcinoma to doxorubicin. Oncotarget. 2017;8:49783\u201395.","journal-title":"Oncotarget"},{"key":"3922_CR14","doi-asserted-by":"publisher","first-page":"638","DOI":"10.5732\/cjc.011.10084","volume":"30","author":"SF Chen","year":"2011","unstructured":"Chen SF, Gong C, Luo M, Yao HR, Zeng YJ, Su FX. Ubc9 expression predicts chemoresistance in breast cancer. Chin J cancer. 2011;30:638\u201344.","journal-title":"Chin J cancer"},{"key":"3922_CR15","doi-asserted-by":"crossref","unstructured":"Huang S, Wang X, Luo K, Zhang X, Liu Z, Li R. Combined Evaluation of mRNA and Protein Expression, Promoter Methylation, and Immune Infiltration of UBE2I in Pan-Digestive System Tumors. Oxidative medicine and cellular longevity. 2022;2022:1129062.","DOI":"10.1155\/2022\/1129062"},{"key":"3922_CR16","doi-asserted-by":"publisher","first-page":"5182","DOI":"10.1038\/onc.2010.251","volume":"29","author":"SH Lee","year":"2010","unstructured":"Lee SH, Bahn JH, Whitlock NC, Baek SJ. Activating transcription factor 2 (ATF2) controls tolfenamic acid-induced ATF3 expression via MAP kinase pathways. Oncogene. 2010;29:5182\u201392.","journal-title":"Oncogene"},{"key":"3922_CR17","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1002\/ddr.22092","volume":"84","author":"H Meng","year":"2023","unstructured":"Meng H, Li J, Sun H, Lin Y, Xu H, Zhang N. The transcription factor ATF2 promotes gastric cancer progression by activating the METTL3\/cyclin D1 pathway. Drug Dev Res. 2023;84:1325\u201334.","journal-title":"Drug Dev Res"},{"key":"3922_CR18","first-page":"2815","volume":"125","author":"E Lau","year":"2012","unstructured":"Lau E, Ronai ZeA. ATF2\u2013at the crossroad of nuclear and cytosolic functions. J Cell Sci. 2012;125:2815\u201324.","journal-title":"J Cell Sci"},{"key":"3922_CR19","doi-asserted-by":"publisher","first-page":"165","DOI":"10.1186\/s40537-023-00844-y","volume":"10","author":"Z Liu","year":"2023","unstructured":"Liu Z, Liu L, Weng S, Xu H, Xing Z, Ren Y, Ge X, Wang L, Guo C, Li L, Cheng Q, Luo P, Zhang J, Han X. BEST: a web application for comprehensive biomarker exploration on large-scale data in solid tumors. J Big Data. 2023;10:165.","journal-title":"J Big Data"},{"key":"3922_CR20","doi-asserted-by":"publisher","first-page":"5892","DOI":"10.1074\/jbc.273.10.5892","volume":"273","author":"R Firestein","year":"1998","unstructured":"Firestein R, Feuerstein N. Association of activating transcription factor 2 (ATF2) with the ubiquitin-conjugating enzyme hUBC9. Implication of the ubiquitin\/proteasome pathway in regulation of ATF2 in T cells. J Biol Chem. 1998;273:5892\u2013902.","journal-title":"J Biol Chem"},{"key":"3922_CR21","doi-asserted-by":"publisher","first-page":"1957","DOI":"10.1097\/CM9.0000000000003225","volume":"137","author":"Y Zhou","year":"2024","unstructured":"Zhou Y, Song K, Chen Y, Zhang Y, Dai M, Wu D, Chen H. Burden of six major types of digestive system cancers globally and in China. Chin Med J. 2024;137:1957\u201364.","journal-title":"Chin Med J"},{"key":"3922_CR22","first-page":"100845","volume":"41","author":"TI Mamun","year":"2024","unstructured":"Mamun TI, Younus S, Rahman MH. Gastric cancer-Epidemiology, modifiable and non-modifiable risk factors, challenges and opportunities: an updated review. Cancer Treat Res Commun. 2024;41:100845.","journal-title":"Cancer Treat Res Commun"},{"key":"3922_CR23","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1007\/s00432-024-05880-6","volume":"150","author":"N Patwa","year":"2024","unstructured":"Patwa N, Chauhan R, Chauhan A, Kumar M, Ramniwas S, Mathkor DM, Saini AK, Tuli HS, Haque S, Slama P. Garcinol in Gastrointestinal cancer prevention: recent advances and future prospects. J Cancer Res Clin Oncol. 2024;150:370.","journal-title":"J Cancer Res Clin Oncol"},{"key":"3922_CR24","doi-asserted-by":"crossref","unstructured":"Russi S, Marano L, Laurino S, Calice G, Scala D, Marino G, Sgambato A, Mazzone P, Carbone L, Napolitano G, Roviello F, Falco G, Zoppoli P. Gene Regulatory Network Characterization of Gastric Cancer\u2019s Histological Subtypes: Distinctive Biological and Clinically Relevant Master Regulators. Cancers. 2022;14.","DOI":"10.3390\/cancers14194961"},{"key":"3922_CR25","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1038\/onc.2009.459","volume":"29","author":"S Zhu","year":"2010","unstructured":"Zhu S, Sachdeva M, Wu F, Lu Z, Mo YY. Ubc9 promotes breast cell invasion and metastasis in a sumoylation-independent manner. Oncogene. 2010;29:1763\u201372.","journal-title":"Oncogene"},{"key":"3922_CR26","doi-asserted-by":"publisher","first-page":"E1724","DOI":"10.1073\/pnas.1415569112","volume":"112","author":"B Yu","year":"2015","unstructured":"Yu B, Swatkoski S, Holly A, Lee LC, Giroux V, Lee CS, Hsu D, Smith JL, Yuen G, Yue J, Ann DK, Simpson RM, Creighton CJ, Figg WD, Gucek M, Luo J. Oncogenesis driven by the ras\/raf pathway requires the SUMO E2 ligase Ubc9. Proc Natl Acad Sci USA. 2015;112:E1724\u201333.","journal-title":"Proc Natl Acad Sci USA"},{"key":"3922_CR27","doi-asserted-by":"publisher","first-page":"1381860","DOI":"10.3389\/fphar.2024.1381860","volume":"15","author":"YN Deng","year":"2024","unstructured":"Deng YN, Chen Y, Gao S, Zhang N, Luo Y, Luo S, Li Q, Fu X, Liang S. RREB1-mediated sumoylation enhancement promotes chemoresistance partially by transcriptionally upregulating UBC9 in colorectal cancer. Front Pharmacol. 2024;15:1381860.","journal-title":"Front Pharmacol"},{"key":"3922_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1038\/s41467-023-44349-x","volume":"15","author":"Q Zhu","year":"2024","unstructured":"Zhu Q, Liang P, Meng H, Li F, Miao W, Chu C, Wang W, Li D, Chen C, Shi Y, Yu X, Ping Y, Niu C, Wu HB, Zhang A, Bian XW, Zhou W. Stabilization of Pin1 by USP34 promotes Ubc9 isomerization and protein sumoylation in glioma stem cells. Nat Commun. 2024;15:40.","journal-title":"Nat Commun"},{"key":"3922_CR29","doi-asserted-by":"crossref","unstructured":"Chen C, Zheng H, Luo Y, Kong Y, An M, Li Y, He W, Gao B, Zhao Y, Huang H, Huang J, Lin T. SUMOylation promotes extracellular vesicle-mediated transmission of lncRNA ELNAT1 and lymph node metastasis in bladder cancer. The Journal of clinical investigation. 2021;131.","DOI":"10.1172\/JCI146431"},{"key":"3922_CR30","doi-asserted-by":"publisher","first-page":"e31213","DOI":"10.1002\/jcp.31213","volume":"239","author":"YP Fan","year":"2024","unstructured":"Fan YP, Lou JS, Jin MR, Zhou CH, Shen HH, Fu CY, Mao XJ, Chen YY, Zhong JJ, Wang LL, Wu JS. UBC9-mediated sumoylation of lamin B1 enhances DNA-damage-induced nuclear DNA leakage and autophagy after spinal cord injury. J Cell Physiol. 2024;239:e31213.","journal-title":"J Cell Physiol"},{"key":"3922_CR31","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1016\/j.molcel.2013.03.027","volume":"50","author":"H Klug","year":"2013","unstructured":"Klug H, Xaver M, Chaugule VK, Koidl S, Mittler G, Klein F, Pichler A. Ubc9 sumoylation controls SUMO chain formation and meiotic synapsis in Saccharomyces cerevisiae. Mol Cell. 2013;50:625\u201336.","journal-title":"Mol Cell"},{"key":"3922_CR32","doi-asserted-by":"publisher","first-page":"109481","DOI":"10.1016\/j.cellsig.2019.109481","volume":"66","author":"GW Fearnley","year":"2020","unstructured":"Fearnley GW, Latham AM, Hollstein M, Odell AF, Ponnambalam S. ATF-2 and Tpl2 regulation of endothelial cell cycle progression and apoptosis. Cell Signal. 2020;66:109481.","journal-title":"Cell Signal"},{"key":"3922_CR33","doi-asserted-by":"publisher","first-page":"e1001258","DOI":"10.1371\/journal.pgen.1001258","volume":"6","author":"M Shah","year":"2010","unstructured":"Shah M, Bhoumik A, Goel V, Dewing A, Breitwieser W, Kluger H, Krajewski S, Krajewska M, Dehart J, Lau E, Kallenberg DM, Jeong H, Eroshkin A, Bennett DC, Chin L, Bosenberg M, Jones N, Ronai ZA. A role for ATF2 in regulating MITF and melanoma development. PLoS Genet. 2010;6:e1001258.","journal-title":"PLoS Genet"},{"key":"3922_CR34","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1002\/cbin.10760","volume":"41","author":"M Li","year":"2017","unstructured":"Li M, Wu X, Liu N, Li X, Meng F, Song S. Silencing of ATF2 inhibits growth of pancreatic cancer cells and enhances sensitivity to chemotherapy. Cell Biol Int. 2017;41:599\u2013610.","journal-title":"Cell Biol Int"},{"key":"3922_CR35","doi-asserted-by":"publisher","first-page":"102564","DOI":"10.1016\/j.redox.2022.102564","volume":"59","author":"X Xu","year":"2023","unstructured":"Xu X, Li Y, Wu Y, Wang M, Lu Y, Fang Z, Wang H, Li Y. Increased ATF2 expression predicts poor prognosis and inhibits sorafenib-induced ferroptosis in gastric cancer. Redox Biol. 2023;59:102564.","journal-title":"Redox Biol"},{"key":"3922_CR36","doi-asserted-by":"publisher","first-page":"2266","DOI":"10.1136\/gutjnl-2021-324834","volume":"71","author":"S Kumar","year":"2022","unstructured":"Kumar S, Schoonderwoerd MJA, Kroonen JS, de Graaf IJ, Sluijter M, Ruano D, Gonz\u00e1lez-Prieto R, Verlaan-de Vries M, Rip J, Arens R, de Miranda N, Hawinkels L, van Hall T, Vertegaal ACO. Targeting pancreatic cancer by TAK-981: a sumoylation inhibitor that activates the immune system and blocks cancer cell cycle progression in a preclinical model. Gut. 2022;71:2266\u201383.","journal-title":"Gut"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03922-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-025-03922-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-025-03922-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,10]],"date-time":"2025-07-10T08:45:45Z","timestamp":1752137145000},"score":1,"resource":{"primary":{"URL":"https:\/\/wjso.biomedcentral.com\/articles\/10.1186\/s12957-025-03922-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,9]]},"references-count":36,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["3922"],"URL":"https:\/\/doi.org\/10.1186\/s12957-025-03922-y","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,9]]},"assertion":[{"value":"28 February 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol by an institutional review board: This study received approval from the Ethics Committee of Fujian Provincial Hospital and was conducted in accordance with the principles of the Declaration of Helsinki. Written informed consent was obtained from all participating patients.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The participating patients gave consent to publish the analysed data in an anonymized form.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no conflict of interest for this article.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}],"article-number":"270"}}